PathoGenetix Protocol Enables Bacterial Identification From Clinical Samples

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WOBURN, Mass., May 16, 2014 (GLOBE NEWSWIRE) -- via PRWEB - PathoGenetix, Inc. has developed and validated a protocol for the identification and subtyping of bacteria directly from human clinical stool samples without prior cultural isolation. The protocol, which runs on the RESOLUTION™ System, enables public health and microbiome research laboratories to determine serotype and strain type information for multiple bacteria directly from an enriched stool sample, in just five hours.

Help employers find you! Check out all the jobs and post your resume.

Back to news